180-Day Exclusivity and Authorized Generics: Legal Considerations in U.S. Drug Markets
The 180-day exclusivity rule rewards the first generic drug maker to challenge a patent - but brand-name companies can undercut them by launching authorized generics. This legal loophole undermines competition and cuts into savings for patients.